NCT01171092View on ClinicalTrials.gov

A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

December 31, 2014

Conditions
Malignant Lymphoma, Stem Cell TypeAutologous Transplant
Interventions
DRUG

bortezomib and G-CSF

"Bortezomib injection:~1.3mg/m2 11 days before and 8 days before the stem cell collection~G-CSF injection:~10mcg/kg on days -4 to day -1 once daily"

Trial Locations (2)

66160

University of Kansas Medical Center, Kansas City

66205

University of Kansas Medical Center, Westwood Campus, Westwood

Sponsors
All Listed Sponsors
collaborator

Millennium Pharmaceuticals, Inc.

INDUSTRY

lead

University of Kansas Medical Center

OTHER